Feedback PLC (AIM:FDBK) CEO Dr Tom Oakley talked with Proactive's Stephen Gunnion about how its flagship product, Bleepa, is transforming healthcare delivery both in the UK and India. Oakley detailed how Bleepa can reduce a typical 30-minute outpatient appointment to just 5-6 minutes, allowing consultants to handle 5-6 times more cases. This efficiency could play a significant role in tackling the NHS elective care backlog.
Following the release of Feedback's half-year report, Oakley highlighted the company’s strategic shift from direct sales to partnerships, including a new arrangement with a leading UK primary care record provider. This partnership embeds Bleepa’s technology into primary care, enhancing scalability and cross-selling opportunities. He emphasised, “It’s laying all the foundation blocks for us getting ever larger contracts.”
Bleepa aligns closely with the UK government’s healthcare priorities, focusing on digital transformation, community-based care, and early intervention. Oakley discussed the potential of the Elective Recovery Fund (ERF) to drive Bleepa’s adoption, despite uncertainties around its continuation beyond March. He also mentioned ongoing pilot programs in Manchester, Buckinghamshire, Sussex, and India, showing promising results in clinical pathways and tuberculosis screenings.
Stay tuned to Proactive’s YouTube channel for more insights from industry leaders. Don’t forget to like this video, subscribe, and turn on notifications for the latest updates!
#FeedbackPLC #Bleepa #HealthcareInnovation #NHSEfficiency #DigitalHealth #IndiaHealthcare #TomOakley #ProactiveInvestors #ElectiveRecoveryFund #MedicalTechnology #PrimaryCare #CommunityHealth #NHS #HealthTech
